December 19, 2017 / 6:05 PM / 9 months ago

BRIEF-FDA To No Longer Grant Orphan Drug Status For Children's Treatments

Dec 19 (Reuters) - U.S. FDA:

* U.S. FDA SAYS ‍​TAKES STEP TO CLOSE ORPHAN DRUG LOOPHOLE THAT LET DRUG DEVELOPERS SIDESTEP PEDIATRIC STUDIES

* U.S. FDA SAYS NO LONGER INTEND TO GRANT PEDIATRIC-SUBPOPULATION DESIGNATIONS THROUGH THE ORPHAN DRUG PROGRAM‍​ Source text: (bit.ly/2BzDV3I) (Bengaluru Newsroom: +91 806 749 1136)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below